Page last updated: 2024-11-02

piracetam and Hepatic Encephalopathy

piracetam has been researched along with Hepatic Encephalopathy in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Godard, JP1
Goerens, C1
Grelier, C1

Other Studies

1 other study available for piracetam and Hepatic Encephalopathy

ArticleYear
Usefulness of piracetam in intensive care.
    Acta anaesthesiologica Belgica, 1976, Volume: 27 suppl

    Topics: Alcoholism; Brain Diseases; Brain Injuries; Carbon Monoxide Poisoning; Cerebrovascular Disorders; Ch

1976